IP Library Granted Patent US 8,604,011
Granted Patent B2
US 8,604,011 · App. 11/576,125 · Granted Dec 10, 2013

Therapy for treatment of chronic degenerative brain diseases and nervous system injury

Inventor: Synthia Mellon (San Francisco, CA)
Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,604,011
App. No.
11/576,125
Granted
Dec 10, 2013
Kind
B2
Abstract

In one aspect the present invention provides neuroactive steroids for use in the treatment of nervous system disorders, degenerative brain diseases and congenital storage diseases. In a second aspect the invention provides neuroactive steroids in combination with a Liver X Receptor (LXR) ligand to effect treatment of a nervous system condition.

Claims (8)

1. A method of treating Niemann-Pick disease in a subject in need of such treatment, said method comprising:

administering to said patient a pharmaceutical formulation comprising a therapeutically effective amount of allopregnanolone and a pharmaceutically acceptable carrier.

2. The method according to claim 1 , wherein said treating comprises administering to said patient a daily dosage of allopregnanolone of from about 10 mg/kg to about 100 mg/kg.

3. The method according to claim 2 , wherein said treating comprises administering to said patient a daily dosage of allopregnanolone of from about 20 mg/kg to about 60 mg/kg.

4. The method according to claim 3 , wherein said treating comprises administering to said patient a daily dosage of allopregnanolone of about 35 mg/kg.

5. The method according to claim 1 , wherein said pharmaceutical formulation is an oral formulation.

6. The method according to claim 1 , wherein said therapeutically effective amount is administered in single or divided daily doses.

7. The method according to claim 1 , wherein said subject is not otherwise in need of treatment with allopregnanolone.

Assignments (3)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jun 10, 2008
From: UNIVERSITY OF CALIFORNIA SAN FRANCISCO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021069/0245 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2008
From: MELLON, SYNTHIA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 020943/0351 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2008
From: ORY, DANIEL
To: WASHINGTON UNIVERSITY IN ST. LOUIS
Reel/Frame 020943/0384 →
Continuity (2)
Provisional Application 60613880 · Sep 27, 2004
Related Publication 20080269183A1 · Oct 30, 2008